EAACI Explains COVID-19

The COVID-19 pandemic that has shaped our new reality is a result of ever-increasing human intrusion into habitats of wild animals and the close interaction with them. The SARS-COV-2 virus jumped the species barrier and sparked the first human COVID-19 infections. Global mass travel fueled one of the most explosive pandemics in modern history. The COVID-19 virus affects humans in various ways, find out more by watching our video.


1  Eva Untersmayr, MD, PhD, Assoc. Prof.; Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Austria

2 Milena Sokolowska, MD, PhD; Swiss Institute of Allergy and Asthma Research, University of Zurich, Switzerland

3  Ioana Agache , MD, PhD, Prof.; Transylvania University, Brasov, Romania

4 Montserrat Alvaro Lozano, MD, PhD. 1) Pediatric Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu, Barcelona, Spain. 2) Institut de Recerca Sant Joan de Déu, Barcelona, Spain. 3) Universitat de Barcelona, Barcelona, Spain. 

5 Laia Alsina Manrique De Lara, MD, PhD; Clinical Immunology and Primary Immunodeficiencies Unit, Pediatric Allergy and Clinical Immunolgy Department, Hospital Sant Joan de Deu, Barcelona, Spain

6 Elisabeth Angier, MRCGP, MSc; University of Southampton, UK

7 Stefania Arasi, MD, PhD; Pediatric Allergology Unit, Department of Pediatric Medicine, Bambino Gesù Children’s research Hospital (IRCCS), Rome, Italy

8  Sarah Ashley, PhD, Murdoch Childrens Research Institute, Australia

9 Barbara Bohle, Department of Pathophysiology, Division of Immunopathology, University of Vienna, Vienna, Austria

10 Matteo Bonini, Department of Cardiovascular and Thoracic Sciences, Catholic University of Rome, Italy

11  Knut Brockow, MD, Prof., Allergy Unit, Department of Dermatology and Allergy Biederstein, Technical University of Munich, Germany

12 Helen Brough, FRCPCH, PhD; 1) Children’s Allergy Service, Evelina London, Guy’s and St. Thomas’ Hospital, London, UK, 2) Department of Women and Children’s Health, School of Life Course Sciences, King’s College London University, London, UK

13 Thomas Chivato, MD, PhD. Prof.; School of Medicine. University CEU San Pablo, Madrid, Spain.

14  Nicolette W. de Jong, PhD, Assoc. Prof.; ErasmusMC, Internal Medicine, section Allergology & Clinical Immunology, Rotterdam, the Netherlands

15 Stefano Del Giacco, Department of Internal Medicine, University of Cagliari, Caligari, Italy

16  Thomas Eiwegger, MD, Assoc. Prof.; 1) Division of Immunology and Allergy, Food Allergy and Anaphylaxis Program, The Department of Pediatrics, The Hospital for Sick Children, Toronto, Canada; 2) Research Institute, The Hospital for Sick Children, Translational Medicine, Toronto, Canada; 3)Department of Immunology, The University of Toronto, Toronto, Canada.

17  Andrzej Eljaszewicz, PhD; Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Bialystok, Poland

18  Ibon Eguiluz Gracia, Allergy Unit, Hospital Regional Universitario de Malaga. Insituto de Investigacion Biomedica de Malaga (IBIMA) and ARADyAL.

19  Stefanie Eyerich, PhD, Assoc. Prof., Center for Allergy and Environment (ZAUM), Helmholtz Center and Technical University Munich; Germany

20  Wojciech Feleszko, MD, PhD, Assoc. Prof.; Department of Pediatric Respiratory Diseases and Allergy, The Medical University of Warsaw, Warsaw, Poland.

21 Philippe Gevaert, MD, PhD, Upper Airway Research Laboratory (URL), Department of Otorhinolaryngology, Ghent University Hospital, Belgium

22 Martin Glatz, MD, PhD

23 Cristina Gomez-Casado, PhD; Institute of Applied Molecular Medicine, Hospitals Madrid (HM) Group, San Pablo-CEU University, Madrid, Spain, ARADyAL, RD16/0006/0015, Thematic Network and Cooperative Research Centers, ISCIII, Madrid, Spain

24  Jan Gutermuth

25  Karin Hoffmann-Sommergruber, PhD, Assoc. ; Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Austria

26 Jozef Janda, Department of Clinical Research‐VPH, Vetsuisse Faculty, University of Bern

27  Rodrigo Jimenez-Siaz, PhD, Assist. ; 1) Dept. Immunology & Oncology, National Center for Biotechnology (CNB-CSIC); 2) McMaster Immunology Research Centre (MIRC), Dept. Pathology & Molecular Medicine, McMaster University

28  Kristina Johansson, PhD

29  Marek Jutel, MD, Prof., 1) Department of Clinical Immunology. Wroclaw Medical University, Wroclaw,  Poland; 2) ALL-MED  Medical Research Institute, Wroclaw, Poland

30 Sandip Kamath, MSc, PhD; Australian Institute of Tropical Health and Medicine, James Cook University, Townsville, Queensland, Australia

31 Edward Knol, PhD, Assoc. Prof.; Depts. Immunology and Dermatology/Allergology, University Medical Center Utrecht, Utrecht, The Netherlands

32  Eugenia Korotchenko, MSc.; Department of Biosciences, Paris-Lodron University of Salzburg, Salzburg, Austria

33 Inge Kortekaas Krohn , PhD, Assist. ; SKIN Research group, Department of Dermatology, Universitair Ziekenhuis Brussel/ Vrije Universiteit Brussel, Brussels, Belgium

34  Susanne Lau, Charité Medical University Berlin, Dpt. of Pediatric Pneumology and Immunology, Germany

35   Maria Luís Marques, MD; Immunoallergology Department, Centro Hospitalar e Universitário do Porto, Porto, Portugal

36  Henry McSorley, MSci, PhD; 1) Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK; 2) Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee, UK

37  Liam O’Mahony, PhD; Prof.; Departments of Medicine and Microbiology, APC Microbiome Ireland, National University of Ireland, Cork, Ireland

38  Oscar Palomares, PhD, Assoc. Prof.; Department of Biochemistry and Molecular Biology, School of Chemistry, Complutense University of Madrid, Madrid, Spain.

39 Isabella Quinti, MD Department of Molecular Medicine, Sapienza University of Rome, Rome

40  Carmen Riggioni-Viquez, MD 1) Allergy and Clinical Immunology, Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore 2) Institut de Recerca Sant Joan de Déu, Barcelona, Spain.

41  Florentina Sava, PhD, Clinical Scientist in Genomics Birmingham Women’s and Children’s Hospital, Birmingham, UK Central and South Genomic Laboratory Hub

42 Mohamed Shamji, Allergy and Clinical Immunology, National Heart and Lung Institute, Imperial College, London, UK MRC Asthma UK

43  Peter Schmid-Grendelmeier, Dept. Of Dermatology, University Hospital of  Zürich

44  Carsten Schmidt Weber, Immunology Unit, Department of Medicine III, University of Leipzig, Leipzig, Germany

45  Jürgen Schwarze, MD, PhD, Prof.; Centre for Inflammation Research, Child Life and Health, The University of Edinburgh, Edinburgh, UK

46  Anna Sediva, MD, PhD; Department of Immunology, Motol University Hospital, Charles University, Prague, Czech Republic

47  Isabel Skypala, PhD; Royal Brompton & Harefield NHS Foundation Trust, Imperial College, London, UK

48  Hermelijn Smits, PhD; Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands

49 Sylwia Smolińska, PhD; Department of Clinical Immunology, Wroclaw Medical University, Poland

50 Olympia Tsilochristou, MD, PhD; Allergy Department​, Guy’s & St Thomas’ Foundation Trust”

51  Maria Jose Torres, MD, Prof.; Allergy Unit, Regional University Hospital of Malaga-IBIMA-UMA-ARADyAL, Malaga, Spain

52   Margitta Worm, MD, Division of Allergy and Immunology, Dpt Dermatology, Venerology and Allergy, Charité Universitätsmedizin Berlin

53  Valerie Verhasselt, Tolérance Immunitaire, Université de Nice Sophia‐Antipolis, Nice, France